내시경 점막하 박리술(ESD) 시장 규모, 점유율과 동향 분석 보고서 : 제품별, 적응증별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Endoscopic Submucosal Dissection Market Summary

The global endoscopic submucosal dissection market size was estimated at USD 391.50 million in 2025 and is projected to reach USD 597.58 million by 2033, growing at a CAGR of 5.40% from 2026 to 2033. The increasing prevalence of gastrointestinal cancers and other related disorders, and advancements in endoscopic technology & instrumentation, drive the demand for diagnostic and therapeutic procedures such as ESD.

For instance, the American Cancer Society estimates that in January 2026, there will be 31,510 new cases of stomach cancer, with 13,610 cases in women and 17,900 cases in men. As esophageal, gastric, and colorectal cancer rates continue to rise globally, the need for advanced procedures, such as ESD, is increasing.

The endoscopic submucosal dissection (ESD) market encompasses an advanced endoscopic procedure used mainly for en bloc removal of superficial neoplastic lesions within the gastrointestinal (GI) tract, particularly in the esophagus, stomach, and colon. In contrast to endoscopic mucosal resection (EMR), which is generally suited for smaller lesions, ESD allows for the complete resection of larger and more complex lesions through precise dissection of the submucosal layer. The procedure relies on specialized tools, including ESD knives, submucosal injection solutions, hemostatic devices, and high-definition endoscopes. ESD plays a critical role in the management of early-stage GI cancers, offering higher curative resection rates, improved pathological evaluation, and preservation of organ integrity.

The aging population worldwide is boosting the demand for ESD. As the global population ages, age-related gastrointestinal conditions, including cancers, are expected to rise. According to the American Cancer Society in January 2026, gastric cancer predominantly affects older individuals, with an average age of 68 when diagnosed, and 6 out of 10 diagnosed annually are 65 or older. Many older patients also have other health conditions, which make traditional surgery riskier, further contributing to the rising demand for ESD procedures.

The growth of the endoscopic submucosal dissection (ESD) market is driven by the rising burden of gastrointestinal (GI) cancers. Key GI cancer types include colorectal, gastric, esophageal, and pancreatic cancers. Factors such as long-standing gastroesophageal reflux disease (GERD), hereditary conditions, gastric infections, chronic gastritis, and the presence of polyps increase the risk of stomach cancer. According to the American Cancer Society (ACS), 152,810 new colorectal cancer cases are expected in the U.S. in 2024, including 106,590 colon cancer cases and 46,220 rectal cancer cases. Colorectal cancer also remains the second leading cause of cancer-related deaths in the country, with an estimated 53,010 deaths projected in 2024. This growing prevalence of GI cancers is significantly driving the demand for advanced, minimally invasive treatments such as ESD, which offer higher curative resection rates and better patient outcomes.

The growing awareness and training programs for healthcare professionals in ESD techniques contribute to market growth. The proficiency of gastroenterologists and surgeons in ESD has been increasing, enhancing both the reach and feasibility of this advanced procedure, particularly in areas that previously had limited access to such treatments. Various medical organizations offer specialized training and certification programs, which are important in gaining knowledge and expertise in ESD. For instance, in April 2024, FUJIFILM Healthcare Europe GmbH introduced EndoGel, an innovative training model designed for performing Peroral Endoscopic Myotomy (POEM) and Endoscopic Submucosal Dissection (ESD) procedures. This simulator is available in two versions such as EndoGel for ESD/POEM and EndoGel for ESD. It is designed to be cost effective for endoscopy professionals and healthcare institutions, aiming to enhance proficiency and patient outcomes through realistic simulation training.

Artificial intelligence (AI) is expected to play an increasingly important role in the future of the ESD market by enhancing lesion detection, characterization, and procedural planning. AI-powered image analysis and real-time decision-support systems can assist endoscopists in accurately identifying lesion margins, assessing invasion depth, and optimizing resection strategies. Furthermore, AI integration with robotic and endoscopic platforms can improve procedural precision, consistency, and outcomes, while supporting training and reducing operator dependency. As AI-enabled endoscopy continues to mature, it is likely to improve clinical efficiency, reduce variability in outcomes, and further expand the adoption of advanced ESD procedures.

Global Endoscopic Submucosal Dissection Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the endoscopic submucosal dissection market on the basis of product, indication, end use, and regions.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Gastroscopes and Colonoscopes
• Knives
• Injection Agents
• Tissue Retractors
• Graspers/ Clips
• Other Products
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Stomach Cancer
• Colon Cancer
• Esophageal Cancer
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals {Including inpatient departments and hospital outpatient departments (HOPDs)}
• Outpatient Facilities {Including ambulatory surgical centers (ASCs), clinics, and other outpatient care settings}
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Indication outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Endoscopic Submucosal Dissection Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Endoscopic Submucosal Dissection: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Trends
• 3.5. Case Study Analysis

Chapter 4. Endoscopic Submucosal Dissection Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Endoscopic Submucosal Dissection Market, by Product, 2021 to 2033
• 4.5. Gastroscopes and Colonoscopes
  • 4.5.1. Gastroscopes and Colonoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Knives
  • 4.6.1. Knives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Injection Agents
  • 4.7.1. Injection Agents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Graspers/ Clips
  • 4.8.1. Graspers/ Clips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Tissue Retractors
  • 4.9.1. Tissue Retractors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Other Products
  • 4.10.1. Other Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Endoscopic Submucosal Dissection Market Segment Analysis, By Indication, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Indication Market Share Analysis, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Endoscopic Submucosal Dissection Market, by Indication, 2021 to 2033
• 5.5. Stomach Cancer
  • 5.5.1. Stomach Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Colon Cancer
  • 5.6.1. Colon Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Esophageal Cancer
  • 5.7.1. Esophageal Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Endoscopic Submucosal Dissection Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2025 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Endoscopic Submucosal Dissection Market, by End Use, 2021 to 2033
• 6.5. Hospitals {Including inpatient departments and hospital outpatient departments (HOPDs)}
  • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Outpatient Facilities {Including ambulatory surgical centers (ASCs), clinics, and other outpatient care settings}
  • 6.6.1. Outpatient Facilities market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Endoscopic Submucosal Dissection Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Endoscopic Submucosal Dissection Market Share by Region, 2025 & 2033:
• 7.5. North America
  • 7.5.1. North America endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. U.S. endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Canada endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Mexico endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. UK endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Germany endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. France endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Italy endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Spain endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Norway endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Sweden endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Denmark endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Japan endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. China endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. India endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Australia endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. South Korea endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Thailand endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Brazil endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Argentina endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. South Africa endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Saudi Arabia endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. UAE endoscopic submucosal dissection market, 2021 - 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Kuwait endoscopic submucosal dissection market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Position Analysis, 2025
• 8.4. Company Profiles
  • 8.4.1. Olympus Corporation
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Boston Scientific Corporation
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. PENTAX Medical (Hoya Corporation)
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. FUJIFILM Holdings Corporation
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Karl Storz GmbH & Co. KG.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Micro-Tech Endoscopy
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Medtronic
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. CONMED Corporation
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. STERIS plc.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Cook Group
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Creo Medical
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives